Anthony Digiandomenico

CIK: 0001083544

Transaction Breakdown

Open Market Buys (P)26 (68.4%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (2.6%)

Derivative conversions

Awards (A)9 (23.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (5.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

EXOZ

EXOZYMES INC.

Director10% Owner

CLIR

ClearSign Technologies Corp

Director

ILLU

Illumination Acquisition Corp. I

Director

NDRA

ENDRA Life Sciences Inc.

Director

MDBH

MDB Capital Holdings, LLC

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (38 total)

EXOZ
EXOZYMES INC.
Oct 1, 2026
Award(A)
Stock Option (right to buy)
Direct
10K shares-
CLIR
ClearSign Technologies Corp
Sep 30, 2026
Award(A)
Non-Statutory Stock Options
Direct
3.8K shares-
CLIR
ClearSign Technologies Corp
Jun 30, 2026
Award(A)
Non-Statutory Stock Options
Direct
4.6K shares-
CLIR
ClearSign Technologies Corp
Mar 31, 2026
Award(A)
Non-Statutory Stock Options
Direct
3K shares-
NDRA
ENDRA Life Sciences Inc.
Jan 21, 2026
Award(A)
Direct
60.3K shares-
NDRA
ENDRA Life Sciences Inc.
Oct 10, 2025
Award(A)
Direct
70.8K shares at avg. $7.06$500K
NDRA
ENDRA Life Sciences Inc.
Jun 11, 2025
Award(A)
Direct
5.4K shares-
MDBH
MDB Capital Holdings, LLC
Apr 28, 2025
Award(A)
Employee Stock Option
Direct
900K shares-
MDBH
MDB Capital Holdings, LLC
Apr 28, 2025
Disposition(D)
RSU
Direct
900K shares-
MDBH
MDB Capital Holdings, LLC
Apr 28, 2025
Award(A)
Employee Stock Option
Direct
900K shares-
MDBH
MDB Capital Holdings, LLC
Apr 28, 2025
Disposition(D)
RSU
Direct
900K shares-
MDBH
MDB Capital Holdings, LLC
Apr 7, 2025
Purchase(P)
Direct
1.4K shares at avg. $4.90$7K
MDBH
MDB Capital Holdings, LLC
Feb 13, 2025
Purchase(P)
Direct
942 shares at avg. $6.15$6K
MDBH
MDB Capital Holdings, LLC
Feb 12, 2025
Purchase(P)
Direct
290 shares at avg. $6.15$2K
MDBH
MDB Capital Holdings, LLC
Feb 11, 2025
Purchase(P)
Direct
1K shares at avg. $6.22$6K
MDBH
MDB Capital Holdings, LLC
Feb 7, 2025
Purchase(P)
Direct
1K shares at avg. $6.22$6K
MDBH
MDB Capital Holdings, LLC
Feb 5, 2025
Purchase(P)
Direct
300 shares at avg. $6.24$2K
MDBH
MDB Capital Holdings, LLC
Feb 4, 2025
Purchase(P)
Direct
398 shares at avg. $6.22$2K
MDBH
MDB Capital Holdings, LLC
Feb 3, 2025
Purchase(P)
Direct
1K shares at avg. $6.17$6K
MDBH
MDB Capital Holdings, LLC
Jan 31, 2025
Purchase(P)
Direct
1K shares at avg. $6.20$6K
MDBH
MDB Capital Holdings, LLC
Jan 30, 2025
Purchase(P)
Direct
100 shares at avg. $6.22$622
MDBH
MDB Capital Holdings, LLC
Jan 29, 2025
Purchase(P)
Direct
14 shares at avg. $6.21$86.94
MDBH
MDB Capital Holdings, LLC
Jan 27, 2025
Purchase(P)
Direct
933 shares at avg. $6.21$6K
MDBH
MDB Capital Holdings, LLC
Jan 24, 2025
Purchase(P)
Direct
164 shares at avg. $6.21$1K
MDBH
MDB Capital Holdings, LLC
Jan 23, 2025
Purchase(P)
Direct
200 shares at avg. $6.24$1K

		Type	Shares	Price		Ownership
Oct 1, 2026	EXOZ EXOZYMES INC.	Award(A) Stock Option (right to buy)	10,000	-	-	Direct
Sep 30, 2026	CLIR ClearSign Technologies Corp	Award(A) Non-Statutory Stock Options	3,766	-	-	Direct
Jun 30, 2026	CLIR ClearSign Technologies Corp	Award(A) Non-Statutory Stock Options	4,595	-	-	Direct
Mar 31, 2026	CLIR ClearSign Technologies Corp	Award(A) Non-Statutory Stock Options	3,024	-	-	Direct
Jan 21, 2026	NDRA ENDRA Life Sciences Inc.	Award(A)	60,324	-	$0	Direct
Oct 10, 2025	NDRA ENDRA Life Sciences Inc.	Award(A)	70,822	$7.06	$500,003	Direct
Jun 11, 2025	NDRA ENDRA Life Sciences Inc.	Award(A)	5,384	-	-	Direct
Apr 28, 2025	MDBH MDB Capital Holdings, LLC	Award(A) Employee Stock Option	900,000	-	-	Direct
Apr 28, 2025	MDBH MDB Capital Holdings, LLC	Disposition(D) RSU	900,000	-	-	Direct
Apr 28, 2025	MDBH MDB Capital Holdings, LLC	Award(A) Employee Stock Option	900,000	-	-	Direct
Apr 28, 2025	MDBH MDB Capital Holdings, LLC	Disposition(D) RSU	900,000	-	-	Direct
Apr 7, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	1,425	$4.90	$6,983	Direct
Feb 13, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	942	$6.15	$5,793	Direct
Feb 12, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	290	$6.15	$1,784	Direct
Feb 11, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	1,000	$6.22	$6,220	Direct
Feb 7, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	1,000	$6.22	$6,220	Direct
Feb 5, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	300	$6.24	$1,872	Direct
Feb 4, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	398	$6.22	$2,476	Direct
Feb 3, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	1,000	$6.17	$6,170	Direct
Jan 31, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	1,000	$6.20	$6,200	Direct
Jan 30, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	100	$6.22	$622	Direct
Jan 29, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	14	$6.21	$87	Direct
Jan 27, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	933	$6.21	$5,794	Direct
Jan 24, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	164	$6.21	$1,018	Direct
Jan 23, 2025	MDBH MDB Capital Holdings, LLC	Purchase(P)	200	$6.24	$1,248	Direct

1-25 of 38 transactions

About DIGIANDOMENICO ANTHONY

DIGIANDOMENICO ANTHONY (SEC CIK 0001083544) files insider reports with the SEC as Director of EXOZYMES INC. (EXOZ), Director of ClearSign Technologies Corp (CLIR) and Director of Illumination Acquisition Corp. I (ILLU). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 27 ownership filings by DIGIANDOMENICO ANTHONY (3 Form 3, 24 Form 4), filed between Nov 18, 2024 and Oct 19, 2026. Those filings report 38 transactions, from Oct 21, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DIGIANDOMENICO ANTHONY's filings is in TULSA, OK.

Recent filings by DIGIANDOMENICO ANTHONY

Oct 1, 2026: Grant or award of EXOZ derivative securities (Form 4, code A).
Sep 30, 2026: Grant or award of CLIR derivative securities (Form 4, code A).
Jun 30, 2026: Grant or award of CLIR derivative securities (Form 4, code A).
Mar 31, 2026: Grant or award of CLIR derivative securities (Form 4, code A).
Jan 21, 2026: Grant or award of NDRA shares (Form 4, code A).

Other insiders filing for EXOZYMES INC. (EXOZ)

Perriman Damien Alan, Chief Commercial Officer
Korman Tyler Paz, Chief Scientific Officer
Rayo Edgardo Javier, Director
MARLETT CHRISTOPHER A, Director
Lalonde James Joseph, Director
Bowie James Ulrich, Director

How to read Form 4 transaction codes